Publicaciones (16) Publicaciones de MARIA LUZ CAÑAVATE ESCRIBANO

2015

  1. Uso del debate sencillo en la plataforma Moodle aplicado a la docencia de Biología Celular en primer curso del Grado de Medicina

    Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de resúmenes XI FECIES

2012

  1. Cell reprogramming, IPS limitations, and overcoming strategies in dental bioengineering

    Stem Cells International

2011

  1. La docencia virtual en asignaturas no troncales

    VIII Foro sobre Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de capítulos

2009

  1. Stem cell and regenerative medicine

    Current Stem Cell Research and Therapy, Vol. 4, Núm. 4, pp. 287-297

2001

  1. Effect of IL-2 and IL-6 on parameters related to metastatic activity in a murine melanoma

    Pathobiology, Vol. 69, Núm. 4, pp. 230-236

2000

  1. Interleukin-2 enhances the growth of human melanoma cells derived from primary but not from metastatic tumours

    European Cytokine Network, Vol. 11, Núm. 4, pp. 654-661

  2. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma

    British Journal of Cancer, Vol. 83, Núm. 7, pp. 847-852

1998

  1. Cyclosporin A upmodulates the α-subunit of the interleukin-2 receptor and the metastatic ability of murine B16F10 melanoma cells

    Invasion and Metastasis, Vol. 18, Núm. 3, pp. 122-133

1997

  1. IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the liver

    Anticancer Research, Vol. 17, Núm. 2 A, pp. 1135-1141

  2. Serum-soluble IL-2 Receptor and IL-6 levels in patients with melanoma

    Oncology (Switzerland), Vol. 54, Núm. 5, pp. 400-406

1996

  1. Expression of IL-2 receptor beta-chain in B16 melanoma cells.

    The International journal of developmental biology, Vol. Suppl 1

  2. Serum interleukin-6 levels in patients with melanoma.

    The International journal of developmental biology, Vol. Suppl 1

1994

  1. Enhancement of ia antigen expression and nonproliferating cells correlates with metastatic capacity

    Pathobiology, Vol. 62, Núm. 4, pp. 186-193

1991

  1. Kinetics and Regulation of NK Activity by Interleukin‐2 and Interferon in Acute Toxoplasmosis

    Scandinavian Journal of Immunology, Vol. 34, Núm. 5, pp. 673-677

1990

  1. EFFET DU TRAITEMENT PAR LA CLINDAMYCINE, L'ERYTHROMYCINE, LA RIFAMYCINE OU LA GENTAMICINE SUR LA CAPACITE D'INGESTION DU MACROPHAGE PERITONEAL DE SOURIS

    Pathologie Biologie, Vol. 38, Núm. 1, pp. 13-18

1989

  1. Are laminin binding sites on tumor cell surface involved in the indomethacin-induced sensitivity to natural cytotoxic cells?

    Biology of the Cell, Vol. 66, Núm. 3, pp. 255-261